Corcept Therapeutics earnings

Next report

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 4, 2025 and Oct 30, 2024, after the close.

Who else reports that week: the earnings calendar.

Last report: Jul 29, 2026, 20:07 ET (after the close). The filing on SEC EDGAR ↗

Across the last 4 reports we hold closes for, the first close moved a median 9.17% either way. Up 3 of 4.

Moves are only shown for reports where we hold closing prices.

1. Jul 29, 202620:07 ET · after the close8-K ↗+27.29%1DRevenue $256.1M+31.7% y/yEPS $0.36quarter to Jun 30, 2026
2. Apr 30, 202620:11 ET · after the close8-K ↗+10.53%1DRevenue $164.9M+4.9% y/yEPS −$0.30quarter to Mar 31, 2026
3. Feb 24, 202621:10 ET · after the close8-K ↗−0.71%1DRevenue $202.1M+11.1% y/yquarter to Dec 31, 2025
4. Nov 4, 202521:08 ET · after the close8-K ↗+7.81%1DRevenue $207.6M+13.7% y/yEPS $0.16quarter to Sep 30, 2025
5. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
6. Jul 31, 202520:07 ET · after the close8-K ↗Revenue $194.4M+18.7% y/yEPS $0.29quarter to Jun 30, 2025
7. May 5, 202520:07 ET · after the close8-K ↗Revenue $157.2M+7.1% y/yEPS $0.17quarter to Mar 31, 2025
8. Feb 26, 202521:06 ET · after the close8-K ↗Revenue $181.9M+34.3% y/yquarter to Dec 31, 2024
9. Oct 30, 202420:09 ET · after the close8-K ↗Revenue $182.5M+47.7% y/yEPS $0.41quarter to Sep 30, 2024
10. Jul 29, 202420:10 ET · after the close8-K ↗Revenue $163.8M+39.1% y/yEPS $0.32quarter to Jun 30, 2024
11. May 1, 202420:09 ET · after the close8-K ↗Revenue $146.8M+39.0% y/yEPS $0.25quarter to Mar 31, 2024
12. Feb 15, 202421:11 ET · after the close8-K ↗Revenue $135.4M+31.4% y/yquarter to Dec 31, 2023
13. Nov 1, 202320:13 ET · after the close8-K ↗Revenue $123.6M+21.5% y/yEPS $0.28quarter to Sep 30, 2023
14. Aug 2, 202320:09 ET · after the close8-K ↗Revenue $117.7M+13.9% y/yEPS $0.25quarter to Jun 30, 2023
15. May 3, 202320:13 ET · after the close8-K ↗Revenue $105.7M+12.8% y/yEPS $0.14quarter to Mar 31, 2023
16. Feb 28, 202321:13 ET · after the close8-K ↗Revenue $103.1M+4.3% y/yquarter to Dec 31, 2022

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. 1 other Item 2.02 filing, filed weeks ahead of a report (a delivery or preliminary update), is not counted as a report. Prior-session closes only; not a forecast, not advice.